cliffmz / Voted
It seems that every day a new American industry asks the US government for a bailout because of impending financial exigency. That said, I was somewhat surprised to learn today that the biotechnology
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Recently, I have come across posts on blogs and websites reporting on lay offs and cost-cutting measures that are taking place at some biotechnology companies. A good example of this is a post that a
read more »
Add this link to...
Bury
Add to:
| Bookmarks
As you all know by now, American pharmaceutical companies have been intermittently laying off thousands of employees for the past two years or so. Many of the employees who have lost their jobs are R
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Bristol-Myers Squibb (BMS) made a presentation this morning at the Credit Suisse Healthcare Conference that showed the company plans on saving an additional $2.5 billion in “productivity initiatives.
read more »
Add this link to...
Bury
Add to:
| Bookmarks
No matter what you may think of Google, you gotta love the brilliance and innovative moxy of the guys who run that company. In today’s New York Times, there was a story about a new web tool called Go
read more »
Add this link to...
Bury
Add to:
| Bookmarks
After months of melodrama and acrimonious exchanges between Jim Cornelius and Carl Icahn, Eli Lilly, not Bristol-Myers Squibb, will acquire ImClone and gain access to the multibillion dollar Erbitux
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Pfizer announced that it will cut R&D jobs and abandon its research efforts in the areas of cardiovascular diseases, cholesterol management, osteoporosis, anemia and liver and muscle diseases. The co
read more »
Add this link to...
Bury
Add to:
| Bookmarks
A contractor who worked for Novartis was charged with running a prostitution ring from his desk at the drug maker’s facility in Hanover, NJ. Luckily (for Novartis anyway) the actual ’services’ were p
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Richmond Va-based INSMED, a US-based follow-on biologics manufacturer, posted a press release on its website entitled: “Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Last year was a banner year for the pharmaceutical lobby (the largest in Washington DC). It spent over $168 million to inform Congress about issues that its members thought were in the best interest
read more »
Add this link to...
Bury
Add to:
| Bookmarks